Impairments and compensation in mouth and limb use in free feeding after unilateral dopamine depletions in a rat analog of human Parkinson's disease.
Rats depleted unilaterally of dopamine (DA) with the neurotoxin 6-hydroxydopamine (6-OHDA) have contralateral sensorimotor deficits. These include pronounced impairments in using the contralateral limbs (bad limbs) for skilled movements in tests of reaching and bar pressing. There has been no systematic examination of the changes that take place in movements of spontaneous food handling. This was the purpose of the present study. Rats were filmed as they picked up and ate pieces of angel hair pasta (Capelli d'Angelo), a food item that challenges the rats to use delicate and bilaterally coordinated limb and paw movements. Control rats picked up the food with their incisors, transferred it to their paws, and manipulated it using a variety of bilaterally coordinated limb and paw movements. The DA-depleted rats were impaired in both their mouth and paw movements. They seemed unable to use their teeth to grasp the food and so used their tongue. They did not use the bad side of their mouth to chew and relied upon the good side of their mouth. The bad paw was impaired in grasping the food, grasped only with a whole paw grip, did not make manipulatory movements, and did not open to release the food or open to regain support once the food was eaten. Although the rats improved over a 30-day recovery period, much of the improvement was due to compensatory adjustments. That unilateral DA-depletion results in profound contralateral impairments of the mouth and limb with improvements due mainly to compensatory adjustments confirms a role for dopaminergic systems in motor control. Additionally, the behavioral tests described here could provide important adjuncts for assessing therapies in this animal analog of human Parkinson's disease.
Whishaw
I Q
IQ
Department of Psychology, University of Lethbridge, Alberta, Canada.
Coles
B L
BL
Pellis
S M
SM
Miklyaeva
E I
EI
D000818:Animals; D001923:Brain Chemistry / Q000502:physiology; D004298:Dopamine / Q000502:physiology*; D005121:Extremities / Q000294:innervation / Q000502:physiology*; D005247:Feeding Behavior / Q000502:physiology*; D005260:Female; D005502:Food; D019416:Head Movements / Q000502:physiology; D009055:Mouth / Q000294:innervation / Q000502:physiology*; D016627:Oxidopamine; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology*; D011597:Psychomotor Performance / Q000502:physiology; D051381:Rats; D012399:Rotation; D013378:Substantia Nigra / Q000187:drug effects / Q000502:physiology; D013565:Sympatholytics; D014743:Videotape Recording
D013565:Sympatholytics; D016627:Oxidopamine; D004298:Dopamine